Cytotoxic T Cells and Interleukin-2 in Treating Adult Patients With Recurrent Brain Tumors

NCT00002572 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Brain and Central Nervous System Tumors

Interventions

BIOLOGICAL: aldesleukin
BIOLOGICAL: muromonab-CD3
BIOLOGICAL: therapeutic tumor infiltrating lymphocytes
PROCEDURE: conventional surgery

Sponsor

University of Colorado, Denver

Collaborators

[object Object]